ARIS and CISO are doing great. It's that giant turd I have leading the bottom that's killing me.
[Reply]

IT'S MEME STOCK DAY!

GME up 14.36% (Chazno)

AMC up 9.37% (Chazno)

CP up 0.71%

SPY up 0.96%

50/58 Green
[Reply]

my NUTR id sell at 90...still hold Corteva and LLY
[Reply]

With U.S. stock markets set to open in two hours, Corteva was up 10.1% in pre-market trading, and Roku Cl A was up 6.4%. DocuSign, Western Digital, and Campbell Soup were all posting gains of at least 4%. Scotts Miracle-Gro and Charles River Labs Intl had posted declines, falling 14.9% and 6.2%, respectively. Stocks in Asia were up overnight, with Japan's NIKKEI 225 Index...
[Reply]

Well it took two weeks, but IOVA finally popped.
Bought at 7.82 and put a trailing stop on it today as it took off which just sold at 9.165.

I'll be keeping an eye to roll the proceeds into next.
[Reply]

Good job!


I just now (10 minutes ago) bought 1700 shares of PRAX at 1.83

It dropped from 8.5 down to 1.79 3 days ago and I waited a bit. It's consolidating nicely and I'm thinking $4 within two weeks.
[Reply]

LOVE showed up on the scanner this morning. Was down to 28 and now back up to 34.50 already. Dropped 20% on a GREAT ER.
[Reply]

Saw that one as well and put it on my watch list, but it seems pretty close to recovered before I was ready to reinvest. We'll see what pops up on the after market list tonight to consider.
[Reply]

With the rectal cancer cure pending I would think now is a good time to buy a long position in GSK. Not sure why it hasn't already bolted. Maybe since the trial was only 12 people they need a bigger study. Volume is up 50% over the 10 day average.
[Reply]

Decent dividend on that one as well. Might be a good one to buy and hold verse shooting for the quick 10%.
[Reply]

I've had a tiny position in GSK for several years, and it's been kind of doggy. No movement up at all and the dividend was the only thing keeping me out of a loss. I've only kept the position because the dividend is nice when I'd otherwise just have the money in cash, and I've sold it down whenever I wanted some cash to buy something else.

It's actually done very well this year relative to the market, though, so I've stopped selling it down. Up 13 percent over the past year with the 4.5 percent dividend, and up 1 percent YTD. That's a big win in 2022.

On a side note, I have a friend who worked at a company that GSK bought. He said they were terrible profitmongers who immediately cut resources and drove down his company's quality of service to save money. So we'll see what they do with the cancer program.
[Reply]

BABA up 14.67% (IowahawkeyeChief)

STAA up 5.62% ( Renegade)

17/58 Green

CP down -0.56%

SPY down -1.09%
[Reply]

I've made an executive decision regarding the Qtr ending June 30th. I think we would be unfair to the integrity of the original challenge if we were to remove our worst performer so I say we keep our original 3 but we're each allowed to add an additional stock for a total of four for each contestant.

The beginning value for the new addition will be the closing price at the end of regular trading hours 6/30/22 .

I've noticed some of the poorer performers in our portfolio making movement so this will allow those to blossom.

And for the next qtr ending 9/30 we will add a 5th stock.

So start thinking about your choice and let me know by 6/30 close.

Also the beginning value of AMZN has changed from 3259 to 163 due to the 20:1 stock split
[Reply]

Watching BOIL closely...
[Reply]

second guessed myself, should have bought in this morning.
[Reply]